These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 17174493)

  • 21. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers.
    Patterson JE; James MB; Forster AH; Rades T
    Drug Dev Ind Pharm; 2008 Jan; 34(1):95-106. PubMed ID: 18214761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of preparation methods on surface/bulk structural relaxation and glass fragility of amorphous solid dispersions.
    Ke P; Hasegawa S; Al-Obaidi H; Buckton G
    Int J Pharm; 2012 Jan; 422(1-2):170-8. PubMed ID: 22079715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.
    Forster A; Hempenstall J; Rades T
    J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E; Georgarakis M; Docoslis A; Bikiaris D
    Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
    Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.